Products currently available in the orthopedics biomaterials market include bone graft substitutes, growth factors, machined allografts, tendon grafts, resorbable fixation devices, cartilage repair, platelet concentration, bone marrow concentration and orthopedic stem cells. These products experienced success in 2011 and will likely grow as a result of continued technology improvements, according to the report.
Changes in healthcare reform and reimbursement will also prompt change in the market.
More Articles on Orthopedic Devices:
TranS1 Q1 Revenue Plummets 26%
Alphatec Spine Q1 Revenue Down, U.S. Hospital Business Grows
20 Orthopedic & Spine Device Company Leaders on the Move
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.